#Pen Needles Market Analysis

[industrynewsupdates]

Pen Needles Market Key Players, Revenue And Growth Rate

The global pen needles market size is estimated to reach USD 7.8 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery. 

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles. 

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Gather more insights about the market drivers, restrains and growth of the Pen Needles Market

Pen Needles Market Report Highlights

• By product, the standard segment dominated the market in 2024, due to the availability of cost-effective needles as compared to safety needles.

• Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements.

• Amongst the needle lengths, 5 mm-sized pen needles segment held the largest share in 2024, due to its optimal balance of comfort and effectiveness for subcutaneous injections.

• Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length.

• Insulin therapy accounted for the largest market share in 2024, due to rising awareness regarding self-administration of insulin amongst the diabetic patients.

• Europe dominated the pen needles market in 2024, followed by North America owing to the high prevalence of diabetes in the European region.

• Asia Pacific region is anticipated to exhibit the significant CAGR over the forecast period, owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery.

Pen Needles Market Segmentation

Grand View Research has segmented the global pen needles market on the basis of product, needle length, therapy, and region:

Pen Needles Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standard Pen Needles

• Safety Pen Needles

Pen Needles Needle Length Outlook (Revenue, USD Million, 2018 - 2030)

• 4mm

• 5mm

• 6mm

• 8mm

• 10mm

• 12mm

Pen Needles Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Insulin

• Glucagon-like-peptide-1

• Growth Hormone

Pen Needles Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

• Latin America

o Brazil

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Pen Needles Market Intelligence Study, published by Grand View Research.

[techninja]

Navigating the Evolving Pen Needles Market: A Deep Dive into the Factors Influencing Market Size, Growth, and Regional Dynamics

Pen Needles Market: Trends, Growth, and Future Outlook

The global pen needles market is poised for significant growth, driven by the increasing prevalence of diabetes and the demand for convenient and safe insulin delivery methods. Pen needles are small, disposable medical devices used with insulin pens to administer medication to individuals with diabetes. The market is expected to reach USD 10 billion by 2033, growing at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2033.

Market Size and Growth

The global pen needles market size was valued at USD 3.5 billion in 2023 and is projected to reach USD 10 billion by 2033, growing at a CAGR of 10.9% from 2024 to 2033. Another report estimates the market size to be USD 1.6 billion in 2023 and is expected to reach USD 2.5 billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028. The market size is expected to reach USD 4.5 billion by 2032, growing at a CAGR of 10.3% from 2023 to 2032.

Market Segmentation

The pen needles market is segmented based on product type, application, length, and distribution channel. The standard pen needles segment dominated the market in 2022, accounting for around USD 1.8 billion revenue. The insulin segment accounted for over 82% business share in 2022 and is anticipated to witness significant growth during the forecast period. The 8 mm segment accounted for over 29% business share in 2022, and the retail pharmacies segment accounted for around USD 1.2 billion revenue size in 2022.

Market Drivers and Challenges

The growth of the pen needles market is driven by the increasing prevalence of diabetes, the surge in demand for self-administration of injectable drugs, and the availability of a wide range of pen needles to meet individual patient needs. Additionally, technological advancements in pen needle manufacturing and safety features, as well as the rise in focus on home healthcare and self-care, are contributing to the market growth. However, safety concerns, such as the risk of accidental needle stick injuries, are a significant restraint of the pen needle market. Proper disposal of used pen needles is crucial to minimize the risk of accidental needle stick injuries and prevent the spread of infectious diseases.

Regional Analysis

The European region dominated the pen needles market in 2023, driven by robust healthcare infrastructure and regulatory excellence. The Asia Pacific region is expected to witness significant growth due to the increasing prevalence of diabetes and the growing demand for insulin delivery devices.

Competitive Landscape

The pen needles market is highly competitive, with several key players focusing on improving awareness regarding insulin delivery devices and their home use. Companies such as Owen Mumford are investing in the development of advanced pen needles with safety features, which is expected to drive the market growth.

Future Outlook

The pen needles market is expected to continue growing as the demand for convenient and safe insulin delivery methods increases. The market is expected to reach USD 10 billion by 2033, driven by technological advancements and government support. The increasing focus on home healthcare and self-care, as well as the growing awareness of diabetes and its risk factors, are expected to contribute to the market growth.

[mukeshdalgavev123]

Insulin Market Analysis 2024 Growth, Trends, and Future Outlook

Insulin Market Overview

The Global Insulin Market has seen continuous development in the past couple of years and is anticipated to grow much further during the forecast period. The exploration introduces a total evaluation of the Insulin Market and contains Future patterns, Current Growth Factors, mindful sentiments, certainties, chronicled information, and factually bolstered and industry-approved market information.

According to Straits Research, the global Insulin market size was valued at USD 19.94 Billion in 2022. It is projected to reach from USD XX Billion in 2023 to USD 22.20 Billion by 2031, growing at a CAGR of 1.2% during the forecast period (2023–2031).

After identifying promising candidates, they undergo extensive testing and optimization to enhance their effectiveness, safety, and pharmacokinetic properties. This entire process of Insulin Market may take several years and necessitates collaboration between scientists from diverse fields such as chemistry, biology, and pharmacology. Irrespective of the challenges encountered during Insulin Market, it has the potential to revolutionize lives by providing new treatments for various diseases.

Request Sample Report of Global Insulin Market @ https://straitsresearch.com/report/insulin-market/request-sample

Competitive Analysis

The report contains an in-depth analysis of the vendor’s profile, including financial health, business units, key business priorities, SWOT, strategies, and views.

Eli Lilly

Novo Nordisk

Biocon

Sanofi Aventis

Wockhardt

Julphar

GSK and SemBioSys.

The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant R&D investments.

Request Sample Report of Global Insulin Market @ https://straitsresearch.com/report/insulin-market/request-sample

Vendors across different verticals are planning for high investments in this market, and as a result, the market is expected to grow at an impressive rate in the upcoming years. The key players are adopting various organic and inorganic growth strategies such as mergers & acquisitions, collaboration & partnerships, joint ventures, and a few other strategies to be in a strong position in the global market.

Market Segmentation Analysis

The report provides a wide-ranging evaluation of the market, providing in-depth qualitative insights, historical data, and supportable projections along with the assumptions about the Insulin Market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendor’s portfolio, blogs, white papers, and vendor presentations. Thus, the research report represents every side of the Insulin Market and is segmented on the basis of regional markets, offerings, applications, and end-users.

By Product Type

Short Acting Human Insulin

Intermediate Acting Human Insulin

Long Acting Human Insulin

Fast-Acting Human Insulin

Premixed Human Insulin

By Delivery System

Syringes

Pens

Pens needles

Pumps

By Application

Type II Diabetes,

Type I Diabetes,

Gestational Diabetes

Pre-diabetes

Access Detailed Segmentation @ https://straitsresearch.com/report/insulin-market/segmentation

Regional Analysis for Insulin Market

The regional analysis offers a comprehensive view of the Insulin Market sales and growth across global and country-level markets. It provides volume and market size data by region, with insights into growth trends in countries like the United States, Canada, Germany, France, China, Japan, and more. The analysis also covers major regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Benefits

Insulin Market Industry companies to ensure business continuity with powerful protection by constantly checking the report and representing attractive growth opportunities for the companies. Insulin Market handles all the needs of the operators by allowing them to improve their services and concentrate on their core business. Insulin Market Research aims to increase business agility and reduce operational and capital expenditure with improved technology rollouts and capacity planning. The report discusses service types and regions related to this Insulin Market. Further, the report provides details about the major challenges affecting the market growth.

Buy Now: https://straitsresearch.com/buy-now/insulin-market

Other Features of the Report:

Provides a thorough analysis of the key strategies with a focus on the corporate structure, R&D methods, localization strategies, production capabilities, sales, and performance in various companies.

Provides valuable insights into the product portfolio, including product planning, development, and positioning.

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

About Us:

StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: Email: sales@straitsresearch.com Website: https://straitsresearch.com/

[mohitbisresearch]

The global pen needle market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.

[waywardunknowntheorist]

Self Injection Device Market Overview, Growth, Opportunities and Development 2030 by Leading Top Players

The Insight Partners stands out as a reliable ally in the syndicated market research and consultation through its steadfast commitment to the market research industry. With extensive experience and proven dedication, we have been delivering outstanding outcomes. With a team of researchers catering to distinct business requirements, we can emerge as a trusted research partner in the past decade.

By prioritizing precision and trust ahead, we are proud to announce the addition of the latest offering titled “Self Injection Device Market Growth Outlook to 2030”. This report ensures spotless coverage of recent updates and a range of business environment factors impacting the Self Injection Device market growth. The meticulous approach opted by our researchers can assist companies in transforming business space into the Self Injection Device market.

Self Injection Device market report offers a comprehensive analysis of regional and global scenarios. The scope of the market report extends to the competitive landscape, cost analysis, key players, specific market regions, profit margin, and market situation. A glance at wide-ranging factors restricting Self Injection Device market growth is deliberately included in this study.

Objectives of Self Injection Device Market Report

To deliver a detailed market overview by integrating quantitative and qualitative analysis

To unveil growth strategies by evaluating the competitive landscape and examining key companies against their position and strategic advantage

To offer estimates on sales volume, market share, size, and CAGR for the projected period.

To offer segment wise insights

This detailed report on Self Injection Device market size is heavily based on verified information and authoritative sources. The study intended to offer market players an overview of market opportunities in the coming period. This report helps clients as a first-hand source of knowledge on the market while providing a full-fledged analysis of each segment.

The study contains details on frontrunners in the market along with their recent collaborations, segments, revenues, product launches, and Self Injection Device market trends. It projects the competition in the Self Injection Device market for an estimated duration. This research further looks at industry channels and the performance of key market players to help businesses stay ahead in the market.

Our Report Sample May Brief On:

Scope of Self Injection Device market report

Brief introduction of Self Injection Device market and Industry Overview

Table of Contents

Top market players covered in this report

Report Structure

Research Methodologies by The Insight Partners

Regional Insights:

This section includes insights on different regions and key players present in the region. This section attempts to analyze the growth of a specific regional market based on economic, technological, and environmental factors. Readers may expect revenue-based data and sales insights gathered by our team after comprehensive research. This informative chapter remains an absolute perk for investors, as it will help them to understand potential investment value and expected returns in specific regions.

Report Attributes

Details

Segmental Coverage

Dosage form

Single Dose

Multi-Dose

Type

Needle Free

Auto

Pen

Wearable Injectors

Geography

North America

Europe

Asia Pacific

and South and Central America

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Becton

Dickinson and Company

West Pharmaceutical Services

Gerresheimer AG

Insulet Corporation

Ypsomed AG

Antares Pharma, Inc.

Consort Medical plc.

Sensile Medical AG.

Other key companies 

Why The Insight Partners?

Proven Expertise: The Insight Partners comprises expert market research analysts who have extensive industry-specific knowledge. Through this report, our team is bringing years of experience to the table while safeguarding the accuracy of insights.

Actionable Insights: TIP relies on a combination of primary and secondary research methodologies that drive tangible results. We are committed to keeping our offerings clear, accessible, and concise to guide businesses in the decision-making process.

Integration of Technology: We embrace technology in all its forms as the core of our research tactics. We use various tools and platforms to analyze and interpret the data. This allows timely results.

Summary:

Current and Future Market Estimates- Self Injection Device Market Share, and Size | 2030

Market Dynamics – Drivers, Challenges, Regional Trends, and Market Opportunities

Market Segmentation – Product, Application, End-use Industries, and Regional Growth Prospects.

Competition Matrix – Key Market Players and Strategies

Recent Developments and Innovation contributing Market Growth

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us: www.theinsightpartners.com

[deshpandeisha]

Exploring the Insulin Delivery Market: Innovations and Impact

The global insulin delivery market size reached USD 17.80 billion in 2021 and is expected to register a revenue CAGR of 9.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing number of diabetes patients across the globe, including increase in obese and elderly population, changes in lifestyles, and adequate/established healthcare services are driving market revenue growth. 

Innovations Driving Change:

Smart Insulin Pens: These high-tech pens track doses, offer reminders, and sync data with apps for better management.

Continuous Glucose Monitors (CGMs): While not traditional delivery methods, CGMs are game-changers, providing real-time glucose levels and reducing the need for frequent injections.

Insulin Pumps: These devices automate insulin delivery, mimicking the pancreas's natural function, offering precise control over glucose levels.

Market Dynamics: The market is buzzing with innovation and competition, pushing companies to create more reliable, affordable, and user-friendly solutions. From traditional syringes to cutting-edge wearable tech, options are expanding.

Impact on Diabetes Management: Improved delivery methods mean better adherence to treatment plans, fewer complications, and enhanced quality of life for those managing diabetes.

Challenges Ahead: Despite advancements, challenges like cost, accessibility, and regulatory hurdles persist, limiting universal access to these innovations.

The leading market contenders listed in the report are: Sanofi Diabetes, Nova Nordisk, Omnipod Insulin Management, Eli Lilly and Company, Gerresheimer, Johnson and Johnson, Becton Dickinson, Medtronic PLC, Hoffmann-La Roche Ltd., Braun

The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs. To Visit Full Report & Table of Contents Insulin Delivery Market: https://www.emergenresearch.com/industry-report/insulin-delivery-market

Market Overview: The report bifurcates the Insulin Delivery market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. Segments Covered in this report are:

Diabetes Type Outlook (Revenue, USD Billion; 2019-2030)

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Prediabetes

Device Type Outlook (Revenue, USD Billion; 2019-2030)

Insulin Syringe

Insulin Pens

Disposable

Reusable

Insulin Jet Injectors

Insulin Pumps

Tethered

Patch

Insulin Needles

Standard Needles

Safety Needles

Insulin Inhalers

External Insulin

Implantable Insulin

Others

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

Oral/Buccal

Nasal

Subcutaneous Route

Transdermal Route

Others

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/1432

Regional Analysis Covers: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key reasons to buy the Global Insulin Delivery Market report:

The latest report comprehensively studies the global Insulin Delivery market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1432

[comparableau]

Pen Needles Market was valued at ~US$ 2 billion in 2020 and is expected to grow at a CAGR of ~12% over the forecast period (2021-2027)

[mitalipingale]

https://rollbol.com/blogs/1773342/Pen-Needles-Market-Overview-Competitive-Analysis-and-Forecast-2031

The Pen Needles Market in 2023 is US$ 3.47 billion, and is expected to reach US$ 8.61 billion by 2031 at a CAGR of 12.00%.

[alicesara611]

Human Insulin Market: Regional Analysis and Forecasts By 2023 to 2030

The human insulin market is expected to grow from US$ 18.95 billion in 2023 to US$ 21.04 billion by 2030, at a CAGR of 1.5% during the forecast period. The major factors driving the growth of the market include the increasing prevalence of diabetes, rising adoption of insulin analogues, and growing awareness about the benefits of human insulin.

The pancreatic beta cells are the source of the hormone insulin. It is essential to the control of blood sugar levels. It manages the processes of the body and determines how well body cells absorb amino acids. aids in the blood's absorption of glucose. A polygenic disorder is a medical illness characterized by elevated {blood sugar, blood glucose, glucose} or glucose levels in the patient. Diabetic retinopathy and diabetic nephropathy are two serious health consequences brought on by this disorder that affects the glucose in the blood tissues. People with diabetes, whose bodies are unable to produce enough insulin to regulate blood sugar levels, need to take insulin on a regular basis.

Get Recently Updated Report of Market as Sample Copy! https://absolutemarketresearch.com/Global-Human-Insulin-Market/1678/request-sample

Over the anticipated years, the market for HI analogs and the rising number of diabetes patients are anticipated to propel the human insulin market. Additionally, positive medical reimbursement scenarios and increased diabetes awareness are expected to drive the market in the upcoming years. Furthermore, the introduction of pen devices and safety pen needles for efficient insulin delivery is anticipated to drive the market during the projected period. Expanding allocations of funds towards research and development endeavors by diverse entities are anticipated to boost market expansion. There are obstacles and limitations that can prevent the market from growing.

Key Trends in the Human Insulin Market:

Some of the key trends in the human insulin market include:

Increasing prevalence of diabetes: Diabetes is a chronic disease that affects millions of people worldwide. The prevalence of diabetes is increasing rapidly due to factors such as obesity, sedentary lifestyle, and unhealthy diet. This is driving the demand for human insulin, which is a life-saving drug for people with diabetes.

Rising adoption of insulin analogues: Insulin analogues are a type of human insulin that is modified to improve its absorption and duration of action. Insulin analogues are more convenient and effective than traditional human insulin, and they are therefore becoming increasingly popular among patients and healthcare professionals.

Growing awareness about the benefits of human insulin: Human insulin is a natural hormone that is produced by the beta cells of the pancreas. It is the most effective and safe type of insulin for people with diabetes. However, many people are not aware of the benefits of human insulin, and they may opt for other types of insulin, such as animal-derived insulin or synthetic insulin. This is creating an opportunity for market players to educate patients and healthcare professionals about the benefits of human insulin.

Key Takeaways:

The global human insulin market is expected to grow from US$ 18.95 billion in 2023 to US$ 21.04 billion by 2030, at a compound annual growth rate (CAGR) of 1.5%.

The increasing prevalence of diabetes and the adoption of insulin analogues are the key factors driving the growth of the market.

The market is segmented by type, distribution channel, type of diabetes, and region.

The modern human insulin segment is expected to dominate the market during the forecast period.

The retail pharmacies segment is expected to be the largest distribution channel for human insulin.

North America is expected to be the largest market for human insulin, followed by Europe and Asia-Pacific.

Key Players in the Human Insulin Market:

The major players in the human insulin market include:

Novo Nordisk A/S

Eli Lilly and Company

Sanofi

Tonghua Dongbao Pharmaceutical Co., Ltd.

Biocon

Wockhardt

Becton, Dickinson and Company

Insulet Corporation

Medtronic plc

Tandem Diabetes Care

Ypsomed AG

These players are focusing on developing and launching new human insulin products that are more affordable and convenient for patients. They are also investing in research and development to improve the efficacy and safety of human insulin.

Segmentation:

By type:

Modern human insulin

Traditional human insulin

By distribution channel:

Retail pharmacies

Hospital pharmacies

Online pharmacies

By type of diabetes:

Diabetes type 1

Diabetes type 2

By region:

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

[cmr-insights]

Pen Needle Market Statistics and Global Analysis Report 2030

The growth of the pen needles market is primarily fueled by increased awareness among consumers. Favorable reimbursement policies and the widespread adoption of pen needles have led to a rise in self-administered insulin usage through insulin pens. The market is also influenced by the trend towards minimally invasive procedures, driven by shorter hospital stays, reduced trauma, and the higher prevalence of chronic conditions like diabetes and obesity. Additionally, factors such as the growing elderly population, improvements in healthcare systems, increased health awareness among consumers, and technological innovations are all contributing to the positive trajectory of the pen needles market. Market players are positioned to capitalize on favorable opportunities during the projected period from 2022 to 2030, driven by the rising demand for biosimilar medications.

Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/pen-needle-market/

The market for safety pen needles has seen an increase in diabetes cases worldwide due to lifestyle changes and a rise in genetic factors among the global population. According to data from the Centers for Disease Control and Prevention (CDC), around 10.5% of the American population (equivalent to 34.2 million individuals) had diabetes, with 26.9 million diagnosed cases and 7.3 million undiagnosed cases. This substantial diabetic population is expected to propel sales growth in the safety pen needles throughout the forecast period.

Global Pen Needle Market Amid COVID-19 Pandemic

The impact of COVID-19 hit various industries hard, and one of those affected was the safety pen needle market, especially as the number of global COVID-19 cases increased. In recent times, there’s been a shortage of important medical supplies and basic medical equipment. The necessity to control the spread of diseases has caused a surge in the demand for specific medical supplies and equipment. We’ve also seen an increase in the overall number of cases, infectious diseases, and mortality rates. More people are requiring critical care, ventilator support, and medical assistance, which means there’s a need for more medical staff and specialists.

The COVID-19 pandemic made a significant impact on over 100 countries, leading the World Health Organization (WHO) to declare it a public health emergency. According to WHO’s estimates, the coronavirus (COVID-19) has infected around 166 million individuals globally.

COVID-19 has influenced the economy in several ways, disrupting supply and demand, causing issues in distribution chains, and affecting businesses and stock markets. Moreover, the healthcare system in the United States saw a noticeable decrease in surgical procedures between March 2022 and June 2022 compared to the same period the prior year. The pandemic had widespread effects on major economies like the US, China, Japan, and various European nations. In response to the growing presence of COVID-19, key players in the US pen needles market are concentrating on creating innovative solutions to lessen the impact of the disease. Both the US and the global economies have felt profound consequences due to the COVID-19 pandemic.

Increasing Prevalence of Chronic Diseases, and Adoption of Novel Drug Delivery Systems, Consumer Awareness & Technological Trends to Boost Global Pen Needle Market

The growth of the pen needles market is being pushed by several factors. These include increased awareness among consumers, favorable reimbursement options, and the wider use of pen needles for self-administering insulin. The market is also being shaped by the trend toward less invasive procedures, shorter hospital stays, the growing occurrence of chronic conditions like diabetes and obesity, the aging population, investments in healthcare systems, people’s heightened awareness of their health, and advancements in technology. The period projected from 2022 to 2030 is anticipated to offer profitable opportunities for market players due to the rising demand for biosimilar medications.

In the pen needles market, a significant factor is the rise in global diabetes cases due to changes in lifestyle and genetic mutations. The CDC’s data shows a substantial number of Americans dealing with diabetes, which is expected to contribute to increased sales in the global pen needles market throughout the forecast period.

Devices for self-injection, particularly pens used for giving biopharmaceuticals subcutaneously, are gaining prominence in the drug delivery device market. The demand for these devices is on the rise because of the introduction of new injectables, the preference for at-home treatments, and the desire for improved patient comfort. The market is witnessing the introduction of next-generation pen needles with enhanced features that benefit both healthcare professionals and patients.

North America to Spearhead the Global Pen Needle Market

The world’s population is aging quickly, particularly in advanced economies like the United States. The World Health Organization (WHO) estimates that the number of elderly people worldwide will increase from 900 million in 2022 to around 2000 million (22% of the world’s population) by 2030. Due to substantial alterations in lifestyle, an increase in malnutrition cases, and genetic abnormalities in the area, it is anticipated that the prevalence of diabetes in North America will climb tremendously in the upcoming years.

Increasing occurrence of chronic disorders: One of the main potential growth elements thought to be responsible for the increased prevalence of chronic diseases in this area is the clinical urgency to use these items.

Favorable Regulatory Environment: The regulatory climate in North America is improving. Pharmaceutical businesses are finding it simpler to launch new drugs since regulatory agencies are creating clearer policies and procedures for the clearance of these therapies.

Adoption of new technology: Adoption of new technologies by the major industries to develop effective medical equipment.

New product development: Intensive new product development activities are carried out to meet the needs demanded by the people for the treatment.

Increased investment in Health care infrastructure: Due to the increase in investment in the healthcare segment North America is leading the drug-device combination products market.

Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/pen-needle-market/

Some of the key players operating in the global pen needles market are Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland),  Terumo Corporation (Japan), Links Medical Products Inc., Arkray Inc., McKesson Medical-Surgical Inc.

[delvenservices]

Needle Market Regional & Value Analysis

Needle Market, By Type (Conventional Needles, Safety Needles), Product (Pen Needles, Suture Needles, Blood Collection Needles, Dental Needles, Insufflations Needles, Ophthalmic Needles, Others), Delivery Mode (Hypodermic, Intravenous, Intramuscular, Others), Material(Glass Needles, Plastic Needles, Stainless Steel/Metallic Needles, Polyetheretherketone (PEEK) Needles), End User (Hospitals, Diagnostic Centers, Diagnostic Centers), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America

Market Overview

The global needle market is anticipated to reach USD 9.24 billion by 2020 growing at a CAGR of 6.2% during the forecasting period, 2020-2028.

Needles are one of the medical tools which are used to put liquid, such as medicines, into the body or to remove a liquid, such as blood, from the body.  It has various types like pen needles, suture needles, blood collection needles, dental needles, insufflations needles, and ophthalmic needles. Factors such as the increasing geriatric population and demand for vaccines are some of the major drivers for the needle market.

Request For Free Sample Report: https://www.delvens.com/get-free-sample/needle-market-trends-forecast-till-2028

Key Findings

The global needle market is segmented into type, product, delivery mode, material, end-user, and geography.

The type segment is segmented into Conventional Needles, Safety Needles. Conventional needles are further segmented into Bevel Needles, Blunt Fill Needles, Vented Needles, Filter Needles. Safety Needles is further segmented into Active Needles and Passive Needles.

The product segment is segmented into Pen Needles, Suture Needles, Blood Collection Needles, Dental Needles, Insufflations Needles, Ophthalmic Needles, and Others

Delivery Mode segment is segmented into Hypodermic, Intravenous, Intramuscular, Others

The material segment is segmented into Glass Needles, Plastic Needles, Stainless Steel/Metallic Needles and Polyetheretherketone (PEEK) Needles

The end-User segment is segmented into Hospitals, Diagnostic Centers, and Diagnostic Centers

Geographically, the global needle market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/needle-market-trends-forecast-till-2028

Regional Analysis

North America region is the largest contributor to the needle market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Competitive Landscape

Key players in the global needle market are

Medtronic PLC, 

Thermo Fisher Scientific Inc.,

Boston Scientific Corporation,

Cook Medical,

Ethicon Us, LLC,

Novo Nordisk A/S,

Becton,

Dickinson And Company,

Stryker Corporation,

Olympus Corporation,

B. Braun Melsungen AG,

Terumo Corporation,

Nipro Corporation,

Ypsomed Holding,

Integra Lifesciences Corporation,

Argon Medical Devices, Inc.,

Galil Medical Inc,

Allison Medical, Inc.,

Hamilton Company,

Precision Medical Products, Inc.,

Unimed Sa,

Smiths Medical,

Sigma-Aldrich,

Aspen Surgical,

A. Menarini Diagnostics,

Vita Needle Company

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

In 2019, Thermo Fisher Scientific Inc has announced to acquire Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies.

In 2019, B. Braun Medical Inc. has announced the launch of Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States

Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.

Purchase the Research report: https://www.delvens.com/checkout/needle-market-trends-forecast-till-2028

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors

Gain authentic and granular data access for needle market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

The Needle Market report answers a number of crucial questions, including:

Which companies dominate the Needle Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[poojascmi]

Global Prefilled Syringes Market is Estimated To Witness High Growth Owing To Increasing Adoption of Self-administration Devices

The global prefilled syringes market is estimated to be valued at US$ 6.44 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Prefilled syringes are ready-to-use medical devices that contain a single dose of a particular medication. These syringes offer numerous advantages over traditional vials and cartridges, including convenience, accuracy in dosing, reduced risk of contamination, and ease of use. Prefilled syringes have gained significant popularity in recent years due to the increasing adoption of self-administration devices. B) Market Key Trends: The key trend driving the growth of the global prefilled syringes market is the increasing adoption of self-administration devices. Patients are increasingly seeking convenient and easy-to-use solutions for administering medications at home. Prefilled syringes provide a reliable and safe option for self-administration, eliminating the need for healthcare professionals or caregivers for routine injections. Moreover, technology advancements, such as autoinjectors and pen injectors, further enhance the ease of self-administration, resulting in increased patient compliance and improved treatment outcomes. For example, the Becton, Dickinson, and Company's BD Intevia Autoinjector is designed for the subcutaneous administration of a range of drugs. It offers a user-friendly interface, delivering accurate dosing and reducing the risk of needle-stick injuries. Such innovations are driving the demand for prefilled syringes in the market. C) PEST Analysis: Political: Government initiatives promoting self-administration devices and the use of prefilled syringes to reduce healthcare costs. Economic: Growing healthcare expenditure and increasing prevalence of chronic diseases driving the demand for prefilled syringes. Social: Increasing preference for self-medication and home healthcare, especially among the elderly population. Technological: Advances in injection technologies, such as autoinjectors and pen injectors, enhancing the ease of self-administration. D) Key Takeaways: - The Global Prefilled Syringes Market Size is expected to witness high growth, exhibiting a CAGR of 5.6% over the forecast period. - Increasing adoption of self-administration devices is a key driver for the market. Patients seek convenient and easy-to-use solutions for administering medications at home. - The Asia Pacific region is expected to be the fastest-growing and dominating region in the market due to the rising geriatric population, increasing healthcare expenditure, and growing awareness about advanced drug delivery systems. - Key players operating in the global prefilled syringes market are Gerresheimer AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A. In conclusion, the global prefilled syringes market is poised to witness significant growth due to the increasing adoption of self-administration devices. These devices provide convenience and accuracy in dosing for patients, driving the demand for prefilled syringes. The Asia Pacific region is expected to be the fastest-growing region in the market. Key players are focusing on technological advancements and product innovations to maintain their market position.

[shubhamresearch]

Pen Needles Market Size to Reach USD 3.5 Billion by 2029, Says The Maximize Market Research.

"Pen needles market" report presents a comprehensive market overview, market shares, and growth opportunities by product, needle length, therapy, and regions. The market size and share for a given segment are estimated by using qualitative and quantitative analysis.

[aishavass]

North America currently dominates the global pen needles market owing to the presence of a large number of people suffering from diabetes...